A biopharmaceutical company should assess its ERP needs when its existing accounting software and spreadsheets can no longer adequately support multiple entities, R&D projects, procurement, payments, and management reporting. The decision should reflect business complexity, rather than employee numbers or revenue alone.
Common signs include difficulty allocating R&D expenses to projects, fragmented purchasing contracts and payment records, inconsistent reporting across domestic and overseas entities, and extensive manual work to understand how funds are being used.
NetSuite’s official life sciences offering covers areas such as financial management, project accounting, and budgeting. The specific functionality required should be confirmed against the company’s needs and subscription configuration.
Melin Tech can help companies assess the scope of implementation by examining how financial and operational data connect. Implementation planning should also define the responsibilities and integration requirements of ERP and specialist laboratory, clinical, and quality management systems.